SCHEMBL5380417

SCHEMBL5380417

CCCOc1ccc(-c2ccc(N)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.60
MAPT P10636 2/20 0.60
MEN1 O00255 1/20 0.60
KMT2A Q03164 1/20 0.60
TDP1 Q9NUW8 2/20 0.59
TSHR P16473 1/20 0.59
NPC1 O15118 6/20 0.56
KDM4E B2RXH2 3/20 0.56
SMN1; SMN2 Q16637 4/20 0.56
ALDH1A1 P00352 3/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
HSD17B10 Q99714 3/20 0.54
CYP1A2 P05177 2/20 0.54
TP53 P04637 1/20 0.54
GAA P10253 1/20 0.54
CYP3A4 P08684 2/20 0.53
CYP2D6 P10635 2/20 0.53
CA12 O43570 1/20 0.52
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL111168 0.94 TDP1 (0.67) RAB9AMAPTMEN1KMT2ATDP1
SCHEMBL7142649 0.92 RAB9A (0.66) RAB9AMAPTMEN1KMT2ATDP1
SCHEMBL17108413 0.89 CYP3A4 (0.63) RAB9AMAPTMEN1KMT2ANPC1
SCHEMBL6836988 0.89 CYP3A4 (0.63) RAB9AMAPTMEN1KMT2ANPC1
SCHEMBL9152649 0.89 CYP3A4 (0.63) RAB9AMAPTMEN1KMT2ANPC1
SCHEMBL31550424 0.88 RAB9A (0.62) RAB9AMAPTMEN1KMT2ATDP1
SCHEMBL27888211 0.88 LTA4H (0.66) RAB9AMAPTMEN1KMT2ATDP1
SCHEMBL21185869 0.87 TDP1 (0.57) RAB9AMAPTMEN1KMT2ATDP1
SCHEMBL23803985 0.86 RARB (0.61) RAB9AMAPTTDP1TSHRNPC1
SCHEMBL10609513 0.86 RARB (0.61) RAB9AMAPTTDP1TSHRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD RAB9A 2271/4885MAPT 1786/4885MEN1 4855/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD RAB9A 2063/4885MAPT 1984/4885MEN1 4861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.